Does the Form 4 for PRECISION BIOSCIENCES INC (DTIL) show any insider share sales?

The Form 4 shows only an acquisition of 107,604 restricted stock units for Dario Scimeca. It does not report any sales or dispositions, reflecting a compensation-related equity grant rather than an open-market transaction.

Precision BioSciences (DTIL) awards 107,604 RSUs to General Counsel

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Scimeca Dario reported acquisition or exercise transactions in this Form 4 filing.

PRECISION BIOSCIENCES INC reported that its General Counsel and Secretary, Dario Scimeca, received a grant of 107,604 restricted stock units. Each unit represents a contingent right to receive one share of the company’s common stock at no purchase price.

The award vests in three substantially equal annual installments beginning on February 18, 2027, conditioned on his continued service with the company through each vesting date. Following this grant, he holds 107,604 restricted stock units directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Scimeca Dario

Role General Counsel and Secretary

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	107,604	$0.00	--

Holdings After Transaction: Restricted Stock Units — 107,604 shares (Direct, null)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Key Figures

RSUs granted: 107,604 units Exercise price: $0.00 per unit Underlying common shares: 107,604 shares +2 more

5 metrics

RSUs granted 107,604 units Restricted stock unit award to General Counsel on June 1, 2026

Exercise price $0.00 per unit No purchase price for RSU grant

Underlying common shares 107,604 shares Each RSU represents one share of common stock

Units after grant 107,604 units Total restricted stock units held following transaction

Vesting start date February 18, 2027 First of three substantially equal annual vesting installments

Key Terms

Restricted Stock Units, contingent right, vests in three substantially equal annual installments, Common Stock

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of the Issuer's Common Stock"

vests in three substantially equal annual installments financial

"Award vests in three substantially equal annual installments beginning on February 18, 2027"

Common Stock financial

"to receive one share of the Issuer's Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/03/2026 - 04:06 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scimeca Dario

(Last)

(First)

(Middle)

C/O PRECISION BIOSCIENCES, INC.

302 E PETTIGREW STREET, SUITE A-100

(Street)

DURHAM

NORTH CAROLINA

27701

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECISION BIOSCIENCES INC [ DTIL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	General Counsel and Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/01/2026		A		107,604		⁽²⁾	⁽²⁾	Common Stock	107,604	$0	107,604	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.

2. Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Remarks:

	/s/ Dario Scimeca	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did PRECISION BIOSCIENCES INC (DTIL) report for Dario Scimeca?

PRECISION BIOSCIENCES INC reported that General Counsel and Secretary Dario Scimeca received 107,604 restricted stock units. These units are a form of equity compensation that may convert into common shares if vesting conditions are satisfied over time.

How many restricted stock units did Dario Scimeca receive from PRECISION BIOSCIENCES INC (DTIL)?

Dario Scimeca received 107,604 restricted stock units from PRECISION BIOSCIENCES INC. Each unit represents a contingent right to receive one share of common stock, providing potential future ownership if vesting conditions are met.

What are the vesting terms for the 107,604 restricted stock units at PRECISION BIOSCIENCES INC (DTIL)?

The 107,604 restricted stock units vest in three substantially equal annual installments starting on February 18, 2027. Vesting is subject to Dario Scimeca’s continued service with the company through each applicable vesting date.

What does each restricted stock unit granted by PRECISION BIOSCIENCES INC (DTIL) represent?

Each restricted stock unit represents a contingent right to receive one share of PRECISION BIOSCIENCES INC common stock. The units convert into shares only as they vest, aligning executive compensation with long-term company performance.